➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
AstraZeneca
Merck
Moodys
Johnson and Johnson

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: MORPHINE SULFATE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

MORPHINE SULFATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Allergan KADIAN morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 020616 NDA Allergan, Inc. 0023-6011-60 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0023-6011-60)
Allergan KADIAN morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 020616 NDA Allergan, Inc. 0023-6012-60 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0023-6012-60)
Allergan KADIAN morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 020616 NDA Allergan, Inc. 0023-6013-60 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0023-6013-60)
Allergan KADIAN morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 020616 NDA Allergan, Inc. 0023-6014-60 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0023-6014-60)
Allergan KADIAN morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 020616 NDA Allergan, Inc. 0023-6015-60 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0023-6015-60)
Allergan KADIAN morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 020616 NDA Allergan, Inc. 0023-6016-60 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0023-6016-60)
Allergan KADIAN morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 020616 NDA Allergan, Inc. 0023-6017-60 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0023-6017-60)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
AstraZeneca
Mallinckrodt
Boehringer Ingelheim
McKinsey